0001415889-22-010919.txt : 20221031 0001415889-22-010919.hdr.sgml : 20221031 20221031174450 ACCESSION NUMBER: 0001415889-22-010919 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221027 FILED AS OF DATE: 20221031 DATE AS OF CHANGE: 20221031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STARKS DANIEL J CENTRAL INDEX KEY: 0000902132 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 221347498 MAIL ADDRESS: STREET 1: ONE ST JUDE MEDICAL DRIVE CITY: ST PAUL STATE: MN ZIP: 55117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-10312022_021041.xml X0306 4 2022-10-27 0000001800 ABBOTT LABORATORIES ABT 0000902132 STARKS DANIEL J 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 true false false false Common shares without par value 2022-10-27 4 S 0 40687 97.3036 D 6882813 D Common shares without par value 2022-10-27 4 S 0 9313 98.136 D 6873500 D Common shares without par value 258 I Alynne Starks 2012 Irrevocable Trust The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.82 to $97.80, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.82 to $98.67, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust. These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). /s/ Daniel J. Starks by Jessica H. Paik, Attorney-in-Fact 2022-10-31